Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 10Myelodysplastic Syndromes 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia 6Hodgkin Disease 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Lymphoma, Non-Hodgkin 4Lymphoma 4Graft vs Host Disease 4Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Waldenstrom Macroglobulinemia 2Multiple Myeloma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Prolymphocytic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Hematologic Neoplasms 2Congenital Abnormalities 2Burkitt Lymphoma 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2beta-Thalassemia 1

Interventions

Specimen Handling 6fludarabine 5Whole-Body Irradiation 5Cytarabine 5Cyclophosphamide 5venetoclax 4Methotrexate 4Biopsy 4merphos 3fludarabine phosphate 3blinatumomab 3N,N-dicyclohexyl-isoborneol-10-sulfonamide 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3prednylidene 2deltacortene 2calaspargase pegol 2Thiotepa 2Tacrolimus 2Stem Cell Transplantation 2Spinal Puncture 2Rituximab 2Prednisone 2Mycophenolic Acid 2Magnetic Resonance Spectroscopy 2Leucovorin 2Filgrastim 2CT-P10 2Busulfan 2Asparaginase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × Mycophenolic Acid × 30 days × Clear all
NCT02220985 2026-06-01

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Fred Hutchinson Cancer Center

Phase 2 Completed
84 enrolled 22 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04195633 2026-05-29

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutchinson Cancer Center

Phase 2 Recruiting
60 enrolled
LymphoidMyeloidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡